Robert Lenz
Net worth: 571 820 $ as of 2026-05-30
Net worth: 571 820 $ as of 2026-05-30
Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-02-17 | 309,092 ( 0.17% ) | 571 820 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Director/Board Member | 2025-08-21 |
| LB PHARMACEUTICALS INC | Director/Board Member | 2026-03-05 |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Producer Manufacturing |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions